SELECT LANGUAGE BELOW

Baldwin calls on drug companies to stop gaming patents for asthma inhalers

Sen. Tammy Baldwin (D-Wis.) is calling on four major inhaler manufacturers to stop inappropriately listing their patents in the Food and Drug Administration’s (FDA) database. This action could delay the introduction of low-cost generic drugs to the market. In a letter sent Monday to AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline (GSK) and Teva, Mr. Baldwin said that […]